Supportive Oligonucleotide Therapy (Q-REstrain) targets specific genes within cancer cells, microorganisms, and viruses to inhibit their growth or survival. By utilizing small oligonucleotide molecules, Q-REstrain aims to disrupt key genetic signals responsible for promoting disease progression.
Oligonucleotides are short RNA molecules containing sequences of nucleotides that store genetic information. In therapeutic applications, they target mRNA to alter gene expression and protein synthesis. Therapeutic Oligonucleotides play a crucial role in treating genetic defects and metabolic disorders by modulating protein production.
Q-REstrain offers a personalized approach to treating various conditions, including cancer and infectious diseases like Lyme disease. Q-REstrain is used to treat solid tumors and hematological malignancies.
The goal of Q-REstrain is to inhibit the expression of proteins that are essential for cell metabolism and/or survival. By precise targeting, Q-REstrain inhibits the survival or growth of cancer cells and pathogens, improving patient outcomes.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“RGCC’s Oncocount test is crucial for monitoring cancer recurrence and guiding long-term treatment strategies. Its precision enables proactive management, improving patient outcomes and quality of life. A vital component of comprehensive cancer care.”
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
Positive test results confirmed the presence of CTCs within six months.
You can use any of the RGCC tests that contain CTC Count results (Example: Oncotrace, Oncotrail or Oncocount, Onconomics, Onconomics Extracts, or Onconomics Plus)
After Q-REstrain administration, the patient should be off all therapies for 7 days.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells. Once testing is complete, your sample is stored for up to six months in case further analysis is needed.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
RGCC tests like Metastat accurately detect the development of secondary tumors.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Indeed, tests are designed to reveal whether cancer cells are resistant or sensitivity to specific drugs and treatments.
Are you looking for personalized approaches to effectively target cancer cells? Supportive Oligonucleotide Therapy (Q-REstrain) is a revolutionary therapy designed to act directly on specific genes of cancer cells, inhibiting their progression. Explore the potential of personalized cancer treatment with Q-REstrain.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
Copyright 2024 © All Right Reserved.
Designed by Bee High Media